Bioada

Rutgers University

The scientific community is continuously trying to improve their understanding of genetic mechanisms in biological systems and finding biomarkers for diagnosis, prognosis and treatment. With growing accessibility, still, only the minority of investigators in the life and medical sciences has the means to analyze and leverage this enormous treasure of data. Bioada is an integrated, easy to use and interactive genomics data analysis platform for the broader community of life scientists.

NanoStem Biotech

Rutgers University

Dr. KiBum Lee of Rutgers University is developing a nanoscaffold material and system that would enable effective stem cell therapy and drug delivery. The innovation promises functional recovery in patients with central nervous system injuries--like spinal cord injuries--for which there are no effective treatments today. Features of the nanoscaffold include 3D biomimicry, stem cell/neuronal differentiation, ECM-protein binding affinity, efficient drug loading/sustained delivery, and MRI-based monitoring capability.

OptoVibronex

Rutgers University

The current standard for distinguishing between benign and cancerous skin legions require an invasive skin biopsy followed by a waiting period for lab results for diagnosis. OptoVibronix is eliminating the need for invasive skin biopses to diagnose a skin legion as cancerous or benign. The technology scans the skin legion and results in a diagnosis in just 15 minutes. By avoiding skin biospy, it improves the patient experience and efficiency of diagnosis and reduces healthcare costs.